Cargando…
Assessment of tumor growth factor-β1 neutralizing antibody in the treatment of allergic rhinitis and asthma
To identify a novel and effective therapy for allergic rhinitis and asthma (ARA), the present study focused on treatment with tumor growth factor (TGF)-β(1) neutralizing antibody. In the present study, four medications were administered to mice with ovalbumin-induced allergic inflammation. Allergic...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772626/ https://www.ncbi.nlm.nih.gov/pubmed/29399067 http://dx.doi.org/10.3892/etm.2017.5501 |